Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesOmar Abdel‐Wahab, Ross L. Levine, Jay Patel et al.|Blood|2009Cited by 718
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Philip Maes, Anthonie W.A. Lensing et al.|The Lancet Haematology|2019Cited by 329